Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis

QR Code

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis

Johanne Sloth Lauszus,1 Peter Lykke Eriksen,1 Mette Mejlby Hansen,1 Lotte Lindgreen Eriksen,1 Debbie Lindsay Shawcross,2,3 Hendrik Vilstrup,1 Karen Louise Thomsen,1 Sidsel Stoy1 1Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark; 2Institute of Liver Studies,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lauszus JS, Eriksen PL, Hansen MM, Eriksen LL, Shawcross DL, Vilstrup H, Thomsen KL, Stoy S
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	neutrophil non-alcoholic fatty liver disease non-alcoholic steatohepatitis oxidative burst cd11b Diseases of the digestive system. Gastroenterology RC799-869
Accès en ligne:	https://doaj.org/article/15c8f198772b47a6a0c79bf6b89717f1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
par: Ana Šinkovec, et autres
Publié: (2021)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
par: Aleksandr I. Pavlov, et autres
Publié: (2021)

Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
par: Chengyuan Liang, et autres
Publié: (2021)

Low-dose LPS promotes progress of non-alcoholic steatohepatitis by up-regulating TLR4 in macrophages
par: YU Yang, et autres
Publié: (2021)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
par: Kaitlin Day, et autres
Publié: (2021)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
par: Jimin Kim, et autres
Publié: (2021)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
par: Hao Xu, et autres
Publié: (2021)

Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy
par: Aline Xavier, et autres
Publié: (2021)

The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
par: Mai BH, et autres
Publié: (2019)

Obesity and nonalcoholic fatty liver disease: current perspectives
par: Sarwar R, et autres
Publié: (2018)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
par: Tetiana Ranhulova
Publié: (2021)

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
par: Mahamid M, et autres
Publié: (2018)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
par: Pegah Golabi, et autres
Publié: (2022)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
par: Cosmas Rinaldi Adithya Lesmana, et autres
Publié: (2019)

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
par: Diaz Soto MP, et autres
Publié: (2020)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
par: Evgenia Pavlovna Kosobyan, et autres
Publié: (2010)

Normalization of Non-Drinking? Health, School Situation and Social Relations among Swedish Ninth Graders That Drink and Do Not Drink Alcohol
par: Jonas Raninen, et autres
Publié: (2021)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
par: Rayvita AN Meagratia, et autres
Publié: (2021)

Chlorogenic Acid Protects against Advanced Alcoholic Steatohepatitis in Rats via Modulation of Redox Homeostasis, Inflammation, and Lipogenesis
par: Vyacheslav Buko, et autres
Publié: (2021)

Alcohol and alcoholism

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
par: Aleksandr E. Nosov, et autres
Publié: (2021)

Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
par: Pierpaolo Coni, et autres
Publié: (2021)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
par: Siyu Yu, et autres
Publié: (2021)

Alcohol and alcoholism.
Publié: (1987)

Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis
par: Sang R. Lee, et autres
Publié: (2018)

Effect of Alcohol to Oral Health
par: Peycheva K., et autres
Publié: (2016)

Current and Potential Therapies Targeting Inflammation in NASH
par: Somaya Albhaisi, et autres
Publié: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
par: Daniela Maria Tanase, et autres
Publié: (2021)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
par: N. V. Mikhaylova, et autres
Publié: (2019)

Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
par: Hegazy MA, et autres
Publié: (2020)

Editorial: New Insights Into Understanding and Managing NAFLD
par: Óscar Escribano, et autres
Publié: (2021)

Typology of Consumers According to the Declared Consumption of Food Products and Non-Alcoholic Beverages. Polish and Slovakian Case Studies
par: Grzegorz Maciejewski, et autres
Publié: (2021)

PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF UNCONTROLLED AND CONTROLLED TYPE 2 DIABETES MELLITUS
par: Aqeela Rashid, et autres
Publié: (2019)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
par: Satoru Hagiwara, et autres
Publié: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
par: Alswat K, et autres
Publié: (2021)

Alcohol-induced liver disease: From molecular damage to treatment
par: Fernández Checa,José C, et autres
Publié: (2002)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
par: Sue Shea, et autres
Publié: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
par: Chen L, et autres
Publié: (2020)

Alcohol research & health the journal of the National Institute on Alcohol Abuse and Alcoholism.
Publié: (1999)

Psychosocial characteristics of alcoholic and non-alcoholic liver disease recipient candidates in liver transplantation: a prospective observational study
par: Masato Shizuku, et autres
Publié: (2021)